pharma news

News

EU warns of brain tumour risk with some contraceptives

EU pharmaceutical safety advisers have said that commonly used contraceptives may carry a small risk of a type of brain cancer with prolonged use.

News

Pay offer rejected as ICR researchers continue strike action

Researchers at the UK Institute of Cancer Research have held historic strikes over pay, claiming they are missing meals and struggling to cover bills.

News

Sleep apnoea drug firm Apnimed files for IPO

Apnimed has joined the IPO queue on the Nasdaq, hoping to raise additional funding for its late-stage oral therapy for obstructive sleep apnoea.

News

Non-profit DNDi preps phase 3 trials for dengue antibody

Non-profit DNDi has licensed a dengue therapy from India's SII, paving the way for a phase 3 trial in Malaysia, Thailand, and Brazil.

News

Bausch + Lomb drug fails in glaucoma, but a new use beckons

Bausch + Lomb has had a hole blown in its pharma pipeline, after disappointing trial results forced it to abandon BL117 for glaucoma.

News

Roche abandons two Huntington's drug candidates

Roche has scrapped two drugs for Huntington's disease – tominersen and RG6496 – after seeing disappointing results in clinical trials.

EU warns of brain tumour risk with some contraceptives

Pay offer rejected as ICR researchers continue strike action

Sleep apnoea drug firm Apnimed files for IPO

Non-profit DNDi preps phase 3 trials for dengue antibody

Bausch + Lomb drug fails in glaucoma, but a new use beckons

Roche abandons two Huntington's drug candidates

Roche, Viking, and Syntis showcase obesity drug candidates

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks